Business ❯ Pharmaceutical Industry

Research and Development

Clinical Trials Cost Reduction Clinical Research Innovation Investment Health Innovations Collaboration Collaborations Market Trends Product Launch Intellectual Property Market Strategy Funding for Health Partnerships Drug Discovery Biopharmaceuticals Clinical Development Innovative Drugs Innovative Methods Investment Strategies Malaria Treatments Corporate Expansion Investment in Health Drug Competition Regulatory Compliance Strategic Decisions Product Development Sanofi Investment Trends Technology Transfer Healthcare Innovation

Boehringer’s Dual-Agonist Survodutide Cuts Body Weight by Up to 16.6% in Phase III Trial

Full results are slated for presentation at the American Diabetes Association meeting in June.

EU Drug Panel Backs Sanofi’s Cenrifki for Non‑Relapsing SPMS

OpenAI Launches GPT-Rosalind, a Biology-Tuned AI for Drug Discovery

Novo’s Triple-Hormone Obesity Drug UBT251 Hits 19.7% Mean Weight Loss in China Phase 2

Sanofi’s Venglustat Notches Gaucher Type 3 Phase 3 Win, Misses Fabry Pain Endpoint

FDA Issues Draft Guidance Easing Primate Tests for Some Antibody Drugs

First New Antimalarial in Decades Tops 97% Cure in Phase III as Novartis Seeks Approval